The orphan nuclear receptors in cancer and diabetes

References

• Giguere V. Orphan nuclear receptors: from gene to function. Endocr Rev 1999;20:689–725
   PubMed Web of Science ®Google Scholar
• Benoit G, Cooney A, Giguere V, et al. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev 2006;58:798–836
   PubMed Web of Science ®Google Scholar
• Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008;29:677–96
   PubMed Web of Science ®Google Scholar
• Schmidt DR, Mangelsdorf DJ. Nuclear receptors of the enteric tract: guarding the frontier. Nutr Rev 2008;66:S88–97
   Google Scholar
• Shiau AK, Coward P, Schwarz M, Lehmann JM. Orphan nuclear receptors: from new ligand discovery technologies to novel signaling pathways. Curr Opin Drug Discov Devel 2001; 4:575–90
   Google Scholar
• Novac N, Heinzel T. Nuclear receptors: overview and classification. Curr Drug Targets Inflamm Allergy 2004;3:335–46
   PubMedGoogle Scholar
• Germain P, Chambon P, Eichele G, et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev 2006;58:760–72
   PubMed Web of Science ®Google Scholar
• Germain P, Chambon P, Eichele G, et al. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 2006;58:712–25
   PubMed Web of Science ®Google Scholar
• Dahlman-Wright K, Cavailles V, Fuqua SA, et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006;58:773–81
   PubMed Web of Science ®Google Scholar
• Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol 2003;65:261–311
   PubMed Web of Science ®Google Scholar
• Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001;81:1269–304
   PubMed Web of Science ®Google Scholar
• Ranhotra HS. The interplay between retinoic acid receptor-related orphan receptors and human diseases. J Recept Signal Transduct 2012;32:181–9
   PubMed Web of Science ®Google Scholar
• Ranhotra HS. The mammalian orphan nuclear receptors: orphans as cellular guardians. J Recept Signal Transduct 2011;31:20–5
   PubMed Web of Science ®Google Scholar
• Pearen MA, Muscat GE. Orphan nuclear receptors and the regulation of nutrient metabolism: understanding obesity. Physiology (Bethesda) 2012;27:156–66
   Google Scholar
• Burris TP, Busby SA, Griffin PR. Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity. Chem Biol 2012;19:51–9
   PubMed Web of Science ®Google Scholar
• Ranhotra HS. The estrogen-related receptors: orphans orchestrating myriad functions. J Recept Signal Transduct 2012;32:47–56
   PubMed Web of Science ®Google Scholar
• Ranhotra HS. The estrogen-related receptor alpha: the oldest, yet an energetic orphan with robust biological functions. J Recept Signal Transduct 2010;30:193–205
   PubMed Web of Science ®Google Scholar
• Deblois G, St-Pierre J, Giguère V. The PGC-1/ERR signaling axis in cancer. Oncogene 2012 (published online, ahead of print)
   Google Scholar
• Deblois G, Giguère V. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat Rev Cancer 2013;13:27--36
   Google Scholar
• Cai Q, Lin T, Kamarajugadda S, Lu J. Regulation of glycolysis and the Warburg effect by estrogen-related receptors. Oncogene 2012 (published online, ahead of print)
   Google Scholar
• Chang CY, McDonnell DP. Molecular pathways: the metabolic regulator estrogen-related receptor α as a therapeutic target in cancer. Clin Cancer Res 2012;18:6089–95
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li Y, Lou G, et al. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS One 2012;7:e39102
   PubMed Web of Science ®Google Scholar
• Qin J, Chen X, Xie X, et al. COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. Proc Natl Acad Sci USA 2010;107:3687–92
   Google Scholar
• Qin J, Chen X, Yu-Lee LY, et al. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res 2010;70:8812–21
   PubMedGoogle Scholar
• Litchfield LM, Klinge CM. Multiple roles of COUP-TFII in cancer initiation and progression. J Mol Endocrinol 2012;49:R135–48
   Google Scholar
• Song CH, Lee HJ, Park E, Lee K. The chicken ovalbumin upstream promoter-transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells. PLoS One 2012;7:e49026
   Google Scholar
• Qin J, Wu SP, Creighton CJ, et al. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis. Nature 2013;493:236--40
   Google Scholar
• Chand AL, Herridge KA, Thompson EW, Clyne CD. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion. Endocr Relat Cancer 2010;17:965–75
   Google Scholar
• Thiruchelvam PT, Lai CF, Hua H, et al. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Res Treat 2011;127:385–96
   Google Scholar
• Chand AL, Wijayakumara DD, Knower KC, et al. The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation. PLoS One 2012;7:e31593
   Google Scholar
• Chand AL, Herridge KA, Howard TL, et al. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts. Steroids 2011;76:741–4
   Google Scholar
• Mendiola M, Carrillo J, García E, et al. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Int J Cancer 2006;118:1381–9
   PubMedGoogle Scholar
• García-Aragoncillo E, Carrillo J, Lalli E, et al. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. Oncogene 2008;27:6034–43
   PubMed Web of Science ®Google Scholar
• Bavner A, Sanyal S, Gustafsson JA, Treuter E. Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol Metab 2005;16:478–88
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang Y, Kemper JK, Wang L. Cross-regulation of protein stability by p53 and nuclear receptor SHP. PLoS One 2012;7:e39789
   Google Scholar
• Zhang Y, Xu P, Park K, et al. Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 2008;48:289–98
   PubMed Web of Science ®Google Scholar
• He N, Park K, Zhang Y, et al. Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology 2008;134:793–802
   PubMedGoogle Scholar
• Zhang Y, Soto J, Park K, et al. Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol Cell Biol 2010;30:1341–56
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011;1812:893–908
   PubMed Web of Science ®Google Scholar
• Seol W, Hanstein B, Brown M, Moore DD. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol Endocrinol 1998;12:1551–7
   PubMedGoogle Scholar
• Johansson L, Thomsen JS, Damdimopoulos AE, et al. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J Biol Chem 1999;274:345–53
   PubMedGoogle Scholar
• Kovacic A, Speed CJ, Simpson ER, Clyne CD. Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes. Mol Endocrinol 2004;18:252–9
   Google Scholar
• Deutsch AJ, Angerer H, Fuchs TE, Neumeister P. The nuclear orphan receptors NR4A as therapeutic target in cancer therapy. Anticancer Agents Med Chem 2012;12:1001–14
   Google Scholar
• Mohan HM, Aherne CM, Rogers AC, et al. Molecular pathways: the role of NR4A orphan nuclear receptors in cancer. Clin Cancer Res 2012;18:3223–8
   PubMed Web of Science ®Google Scholar
• McMorrow JP, Murphy EP. Inflammation: a role for NR4A orphan nuclear receptors? Biochem Soc Trans 2011;39:688–93
   PubMed Web of Science ®Google Scholar
• Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 2009;7:e003
   PubMedGoogle Scholar
• Kim DK, Ryu D, Koh M, et al. Orphan nuclear receptor estrogen-related receptor γ (ERRγ) is key regulator of hepatic gluconeogenesis. J Biol Chem 2012;287:21628–39
   Web of Science ®Google Scholar
• Jeong JY, Jeoung NH, Park KG, Lee IK. Transcriptional regulation of pyruvate dehydrogenase kinase. Diabetes Metab J 2012;36:328–35
   Google Scholar
• Zhang Y, Ma K, Sadana P, et al. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem 2006;281:39897–906
   PubMed Web of Science ®Google Scholar
• Pei L, Waki H, Vaitheesvaran B, et al. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 2006;12:1048–55
   PubMed Web of Science ®Google Scholar
• Berriel Diaz M, Lemke U, Herzig S. Discovering orphans' sweet secret: NR4A receptors and hepatic glucose production. Cell Metab 2006;4:339–40
   PubMed Web of Science ®Google Scholar
• Fu Y, Luo L, Luo N, et al. NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J Biol Chem 2007;282:31525–33
   Google Scholar
• Pearen MA, Muscat GE. Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 2010;24:1891–903
   PubMed Web of Science ®Google Scholar
• Myers SA, Eriksson N, Burow R, et al. β-Adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues. Mol Cell Endocrinol 2009;309:101–8
   PubMed Web of Science ®Google Scholar
• Kanzleiter T, Schneider T, Walter I, et al. Evidence for Nr4a1 as a cold-induced effector of brown fat thermogenesis. Physiol Genomics 2005;24:37–44
   Google Scholar
• Chao LC, Wroblewski K, Ilkayeva OR, et al. Skeletal muscle Nur77 expression enhances oxidative metabolism and substrate utilization. J Lipid Res 2012;53:2610–19
   PubMed Web of Science ®Google Scholar
• Miao J, Xiao Z, Kanamaluru D, et al. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev 2009;23:986–96
   PubMed Web of Science ®Google Scholar
• Yang Z, Wu S, Zheng T, et al. Gender-dependent penetrance of small heterodimer partner (SHP) gene deficiency in overweight/obese Chinese pedigrees. J Int Med Res 2010;38:142–9
   Google Scholar
• Enya M, Horikawa Y, Kuroda E, et al. Mutations in the small heterodimer partner gene increase morbidity risk in Japanese type 2 diabetes patients. Hum Mutat 2008;29:E271–7
   PubMedGoogle Scholar
• Moore DD. Nuclear receptors reverse McGarry's vicious cycle to insulin resistance. Cell Metab 2012;15:615–22
   PubMed Web of Science ®Google Scholar
• Kim YD, Park KG, Lee YS, et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 2008; 57:306–14
   PubMed Web of Science ®Google Scholar
• Meissburger B, Ukropec J, Roeder E, et al. Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma. EMBO Mol Med 2011;3:637–51
   PubMed Web of Science ®Google Scholar
• Tinahones FJ, Moreno-Santos I, Vendrell J, et al. The retinoic acid receptor-related orphan nuclear receptor γ1 (RORγ1): a novel player determinant of insulin sensitivity in morbid obesity. Obesity (Silver Spring) 2012;20:488–97
   PubMed Web of Science ®Google Scholar